UPDATE 3-Sanofi to cut US price of its most-prescribed insul

Sanofi SA said late on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78 per cent starting next year after similar..

Related Keywords

California , United States , France , Utah , French , Americans , American , Lantus Solostar , Inmaculada Hernandez , Eli Lilly , Joe Biden , University Of California At San Diego , American Diabetes Association , Novo Nordisk , Reuters , Sanofi Pharmaceutical , Inflation Reduction , American Diabetes , Business ,